Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up

Chemours Co

Basic Materials · Specialty Chemicals

14.50$ +1.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Chemours Co (CC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,591 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CC
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,398	1,322	1,437	1,588	1,584	1,575	1,730	1,816	1,628	1,464	1,376	1,408	1,390	1,353	1,305	1,093	1,233	1,338	1,436	1,655	1,680	1,575	1,764	1,915	1,777	1,338	1,536	1,643	1,487	1,412	1,362	1,554	1,501	1,394	1,368	1,615	1,495	1,330	1,381	1,591	5,797
Cost of Revenue	1,056	1,023	1,079	1,147	1,117	1,088	1,193	1,259	1,151	1,064	1,080	1,085	1,096	1,203	1,007	894	976	1,025	1,139	1,391	1,253	1,182	1,278	1,418	1,345	1,136	1,168	1,233	1,214	1,157	1,078	1,246	1,215	1,121	1,132	1,337	1,260	1,177	1,166	1,305	4,908
Gross Profit	342	299	358	441	467	487	537	557	477	400	296	323	294	150	298	199	257	313	297	264	427	393	486	497	432	202	368	410	273	255	284	308	286	273	236	278	235	153	215	286	889
Research & Development	19	20	19	21	20	19	20	20	20	21	22	19	20	19	24	20	22	26	24	27	27	29	30	25	32	30	26	28	28	15	28	26	29	26	27	28	26	27	26	27	106
Selling, General & Administrative	148	480	144	157	148	158	143	161	163	191	156	136	130	125	125	110	112	180	139	172	124	159	141	254	140	175	124	779	165	223	139	139	135	144	123	437	109	130	147	469	855
Total Operating Expenses	167	500	163	178	168	177	163	181	183	212	178	155	150	167	150	131	135	207	159	205	154	186	172	277	173	206	150	215	163	148	171	178	164	198	158	206	131	412	151	499	1,193
Operating Income	175	-201	195	263	299	310	374	376	294	188	118	168	144	-17	148	68	122	106	138	59	273	207	314	220	259	-4.0	218	195	110	107	113	130	122	75	78	72	104	-259	64	-213	-304
Interest Expense	51	56	51	54	55	54	52	48	47	47	51	52	53	52	54	53	53	50	49	47	45	43	41	40	41	40	42	48	55	63	63	66	69	67	66	66	68	69	68	68	273
Pre-Tax Income	234	-273	173	225	250	263	381	323	269	182	107	133	91	-454	77	20	60	23	101	44	231	302	280	231	299	-69	173	-433	13	-69	70	69	-30	9.0	78	-261	51	-145	-22	-1.0	-117
Income Tax Expense	30	-43	22	64	43	35	84	41	-6.0	40	13	37	15	-137	-23	-4.0	-16	4.0	5.0	-22	17	69	46	30	59	28	28	-57	1.0	-53	16	9.0	-3.0	17	82	119	-9.0	-83	7.0	273	188
Net Income	204	-230	150	161	207	228	297	281	275	142	94	96	76	-317	100	24	76	19	96	66	214	233	234	201	240	-97	145	-376	12	-18	54	60	-27	-8.0	-4.0	-381	60	-61	-29	-274	-304
EBITDA	248	-145	258	324	361	379	451	441	369	268	197	243	222	-323	210	154	193	185	233	171	355	281	395	343	411	45	294	-307	144	170	204	209	117	154	154	-115	198	-76	125	-413	-166

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings